2025 Crohn's and Colitis Conference
Overview
The agenda includes sessions on Artificial Intelligence in IBD, New medications in IBD, Head to Head Trials in IBD Therapy, De-Escalation of IBD Therapy, Anti-Obesity (GLP-1) Medications in IBD, IBD and Uveitis, Surgical Approaches to Ileal Pouches, Successful Transition from Pediatric to Adults IBD Practice, and IBD and Dietary Considerations.
Target Audience
Learning Objectives
- Evaluate the latest updates in the medical and surgical management of inflammatory bowel disease (IBD) to optimize patient outcomes and tailor therapy based on disease severity and patient-specific factors.
- Assess the efficacy and safety of novel biologic and small molecule therapies for Crohn’s disease and ulcerative colitis, including positioning these therapies in treatment algorithms.
- Discuss the role of therapeutic drug monitoring (TDM) and de-escalation strategies in managing long-term IBD therapy to balance disease control and minimize risks.
Program
Crohn’s and Colitis Foundation Conference:
A Patient and Provider Point of Care Conference
7:30-7:45 Registration and Continental Breakfast
7:45-8:00 Welcome and Introductions
Dr. Poonam Beniwal-Patel, Dr. Daniel Stein & Crohn’s and Colitis Foundation
8:00-8:45 Artificial Intelligence in Inflammatory Bowel Disease
Dr. Ryan Stidham, Keynote Speaker
8:45-9:05 New Medications in IBD
Dr. Daniel Stein
9:05-9:25 Head to Head Trails in IBD Therapy
Dr. Preetika Sinh
9:25-9:45 De-Escalation of IBD Therapy
Dr. Dilpesh Agrawal
9:45-9:50 Questions
9:50-10:00 BREAK
10:00-10:20 Anti-Obesity (GLP-1) Medications in IBD
Dr. Poonam Beniwal-Patel
10:20-10:40 IBD and Uveitis
Dr. Edward Randerson
10:40-11:00 Surgical Approaches to Ileal Pouches
Dr. Katherine Hu
11:00-11:05 Questions
11:05-11:20 Successful Transition from Pediatric to Adult IBD Practice
Dr. Amanda Wenzel
11:20-11:40 IBD and Dietary Considerations
Kirsten Kane, MS, RD, CSO, CD
11:40-11:45 Questions
11:45-12:45 Working Lunch: Case Based Discussion
12:45-1:00 Wrap-Up
Venue
Faculty
Dislpesh Agrawal, MD; Assistant Professor of Medicine
Name | Company | Role |
Daniel Stein, MD | Abbvie, Lilly, Bristol Myers Squibb | Consultant/Speaking/Teaching |
Ryan Stidham, MD | Johnson and Johnson, Merck, Bristol Myer Squibb | Consultant, Advisory Committee, Researcher |
Preetika Sinh, MD | Bristol Myers Squibb | Consultant, Advisory Committee |
Accreditation
Hours of Participation for Allied Health Care Professionals
The Medical College of Wisconsin designates this activity for up to 5.00 hours of participation for continuing education for allied health professionals.
Available Credit
- 5.00 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 5.00 Hours of ParticipationHours of Participation credit.
Register/Take course
Price
Do I already have an account?
Have you ever used ocpe.mcw.edu? For example, if you have taken an activity accredited by the Medical College of Wisconsin, then you already have an account.
If you have forgotten your username/password, you can
retrieve it nowRegistration scams:
Registration for courses managed by MCW Office of Continuing Professional Development can only be completed through our portal at https://ocpe.mcw.edu/. Course registrations made through other sites cannot be honored. MCW Office of Continuing Professional Development is not able to refund fees paid through unaffiliated registration sites, such as eMedEvents.com, MedConfWorld.com, EventEgg.com, and 10times.com.
Please report any unauthorized websites or solicitations for registrations to cme@mcw